LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets

LIGAND PHARMACEUTICALS INCORPORATED Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets

LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) had Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets of $27.50 million as of 2010-01-31, per its 10-K filed 2016-11-14.

Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation

us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets · last filed 2016-11-14

• 2010-01-31: Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets $27.50M.